Variant report
Variant | nsv965169 |
---|---|
Chromosome Location | chr3:54338938-54339534 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112754601 | chr3:54338940-54338941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144451506 | chr3:54338947-54338948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567345371 | chr3:54338951-54338952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76115721 | chr3:54338954-54338955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114782771 | chr3:54338956-54338957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4078007 | chr3:54338979-54338980 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs575339041 | chr3:54338987-54338988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376642913 | chr3:54338988-54338989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576237734 | chr3:54339040-54339041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544443985 | chr3:54339047-54339048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7635568 | chr3:54339087-54339088 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs7627905 | chr3:54339118-54339119 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs540553900 | chr3:54339131-54339132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560168741 | chr3:54339244-54339245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs151193624 | chr3:54339313-54339314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542349551 | chr3:54339332-54339333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7616533 | chr3:54339365-54339366 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs181574776 | chr3:54339372-54339373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6445644 | chr3:54339415-54339416 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs565154591 | chr3:54339448-54339449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527378118 | chr3:54339492-54339493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376792452 | chr3:54339494-54339495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186551891 | chr3:54339496-54339497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547713959 | chr3:54339504-54339505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559117544 | chr3:54339522-54339523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190955102 | chr3:54339534-54339535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Septo-optic dysplasia | 21572526 | CNVD |
Biliary cancer | 19435499 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Ventriculomegaly | 21325761 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Lung cancer | 16618734 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:54332200-54343600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr3:54334000-54343200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr3:54336800-54340600 | Weak transcription | Aorta | Aorta |
4 | chr3:54337600-54339800 | Enhancers | Fetal Stomach | stomach |
5 | chr3:54338000-54339800 | Enhancers | Liver | Liver |
6 | chr3:54338000-54339800 | Enhancers | Duodenum Smooth Muscle | Duodenum |
7 | chr3:54338200-54339000 | Enhancers | Brain Germinal Matrix | brain |
8 | chr3:54338200-54339000 | Enhancers | Brain Hippocampus Middle | brain |
9 | chr3:54338400-54343200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr3:54338400-54345400 | Weak transcription | Fetal Lung | lung |
11 | chr3:54338600-54339600 | Enhancers | Rectal Smooth Muscle | rectum |
12 | chr3:54338800-54340600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:54338800-54341400 | Weak transcription | Fetal Muscle Leg | muscle |
14 | chr3:54339000-54339400 | Weak transcription | Brain Germinal Matrix | brain |
15 | chr3:54339000-54339800 | Enhancers | Colon Smooth Muscle | Colon |
16 | chr3:54339400-54339600 | Enhancers | Brain Germinal Matrix | brain |